Trial intelligence / Profile preview

Long-term immunity after primary tick-borne encephalitis vaccination in older adults

2012-004231-24Phase 4Completed

Sponsor
Medical University of Vienna, Department of Virology
Start
Feb 2013
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Medical University of Vienna, Department of Virology. Started Feb 2013; status: completed.

02

Drugs

FSME-IMMUN
03

Conditions

tick-borne encephalitis (TBE)

Beyond the preview

Go deeper on 2012-004231-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004231-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call